Karen Zusi January 7, 2016 Researchers have engineered a Cas9 variant that produces almost no detectable gene-editing errors in the CRISPR/Cas9 system. Study co-authors Vikram Pattanayak (Mass General) and J. Keith Joung (Mass General) are quoted. Read the full article
The Economic Forces That Drive Prescription Drug Prices October 30, 2025 Luca Maini on what new U.S. policies could mean for patients and health systems
HMS Announces Blavatnik Institute Early Career Investigator Awards November 6, 2025 10 projects receive basic and translational research funding
CTE Is Caused by More Than Head Trauma, New Study Suggests October 30, 2025 Research reveals Alzheimer’s disease-like DNA damage, hints at immune involvement
